Suchergebnisse - "Humans"

PubPharm (150)

1

A novel SETD3-ALK fusion in lung adenocarcinoma and sustained clinical response to crizotinib

enthalten in: Lung cancer (Amsterdam, Netherlands) | 2023

von Dai, S. | Liu, X. | Wu, Q. | +5

2

Case Report : Specific ABL-Inhibitor Imatinib Is an Effective Targeted Agent as the First Line Therapy to Treat B-Cell Acute Lymphoblastic Leukemia With a Cryptic NUP214::ABL1 Gene Fusion

enthalten in: Pathology oncology research : POR | 2022

von Stukaite-Ruibiene, E. | Norvilas, R. | Dirse, V. | +2

3

Extrapulmonary tuberculosis in patients with RET fusion-positive non-small cell lung cancer treated with pralsetinib : A Korean single-centre compassionate use experience

enthalten in: European journal of cancer (Oxford, England : 1990) | 2021

von Lee, Y. | Jeong, B. | Eun, Y. | +8

4

Crizotinib : aseptic abscesses in multiple organs during treatment of EML4-ALK-positive NSCLC

enthalten in: Journal of cancer research and clinical oncology | 2021

von Weber, D. | Decker, M. | Schuster, M. | +3

5

Novel MLL/KMT2A-MON2 fusion in a child with therapy-related acute myeloid leukemia after treatment for acute promyelocytic leukemia

enthalten in: Molecular carcinogenesis | 2021

von Gong, Y. | Wang, M. | Shen, H. | +4

6

A novel HNRNPC-RARA fusion in acute promyelocytic leukaemia lacking PML-RARA rearrangement, sensitive to venetoclax-based therapy

enthalten in: British journal of haematology | 2021

von Liu, M. | Zhao, X. | Pan, W. | +5

7

Whole-process Management of Treatment of Advanced ALK Positive Non-small Cell Lung Cancer : A Case Report

enthalten in: Zhongguo fei ai za zhi = Chinese journal of lung cancer | 2021

von Bai, H. | Han, Y. | Niu, Y. | +1

8

Rapid Response to Lorlatinib in a Patient With TFG-ROS1 Fusion Positive Inflammatory Myofibroblastic Tumor of the Chest Wall Metastatic to the Brain and Refractory to First and Second Generation ROS1 Inhibitors

enthalten in: Journal of pediatric hematology/oncology | 2021

von Carcamo, B. | Bista, R. | Wilson, H. | +2

9

Partial Response to Sorafenib in a Child With a Myeloid/Lymphoid Neoplasm, Eosinophilia, and a ZMYM2-FLT3 Fusion

enthalten in: Journal of pediatric hematology/oncology | 2021

von Munthe-Kaas, M. | Forthun, R. | Brendehaug, A. | +6

10

Larotrectinib followed by selitrectinib in a novel DCTN1-NTRK1 fusion undifferentiated pleomorphic sarcoma

enthalten in: Journal of oncology pharmacy practice : official publication of the International Society of Oncology Pharmacy Practitioners | 2021

von Goh, X. | Seng, M. | Loh, A. | +3

1
2
3
4
5
6
7
8
9
10
11
Nächster »
[15]